Advertisement

Expert Point of View: David Graham, MD, FASCO


Advertisement
Get Permission

David Graham, MD, FASCO

David Graham, MD, FASCO

ASCO EXPERT David Graham, MD, FASCO, Medical Director at the Levine Cancer Institute in Charlotte, North Carolina, was enthusiastic about this new technology. “This is an important first step showing there is an easier way to detect lung cancer at earlier stages. If the promise of this report holds, we could easily envision a day when a patient can be screened for lung cancer and other cancers by going to the doctor’s office for a blood draw,” Dr. Graham said. 

“In this very early trial, the rate of specificity is very high, which few other technologies have,” Dr. Graham noted. “If the technology becomes available, we will need to determine who would use it and how it would be used. It would be easy for a primary care doctor to add this to the blood tests patients already have.” ■

DISCLOSURE: Dr. Graham reported no conflicts of interest. 


Related Articles

Genome Sequencing of Blood Samples May Lead to Detection of Early- Stage Lung Cancer

IF THE INITIAL promise of research presented at the 2018 ASCO Annual Meeting bears fruit, we may one day have a simple blood test to screen for early-stage lung cancer and possibly other cancers. Although it is still very early days for this test, an initial report from the ongoing Circulating...

Advertisement

Advertisement



;
Advertisement

By continuing to browse this site you permit us and our partners to place identification cookies on your browser and agree to our use of cookies to identify you for marketing. Read our Privacy Policy to learn more.